参考文献/References:
[1]赵广明,胡占升.脓毒症肝损伤的发病机制与治疗研究进展[J].解放军医学杂志,2019,44(6):515-520.
[2] 陈 琛,苏 华,蒋丽娜,等.TNF-α和IL-10与重症脓毒症患者预后的相关性研究[J].陕西医学杂志,2016,45(12):1600-1601.
[3] 周 群,吴宝明,孟晓明,等.Kv1.3在LPS诱导的小鼠急性肝损伤模型中表达变化[J].安徽医科大学学报,2016,51(5):649-655.
[4] Jo EK,Kim JK,Shin DM,et al.Molecular mechanisms regulating NLRP3 inflammasome activation[J].Cell Mol Immunol,2016,13(2):148-159.
[5] Chen J,Chen ZJ.PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation[J].Nature,2018,564(7734):71-76.
[6] Xu T,Du Y,Fang XB,et al.New insights into Nod-like receptors(NLRs)in liver diseases[J].Int J Physiol Pathophysiol Pharmacol,2018,10(1):1-16.
[7] 姜 帅.黄芪多糖对游离脂肪酸所致人血管内皮细胞NLRP3炎性小体表达的影响[J].陕西中医,2019,40(9):1165-1169,1314.
[8] 李 南,孙妩弋,孙家昌,等.炎症小体在纤维化疾病中作用的研究进展[J].中国药理学通报,2020,36(4):479-483.
[9] 王红钢,孙伟力,钟培育,等.外源性硫化氢对肝细胞NLRP3炎症小体的影响[J].中国病理生理杂志,2018,34(1):118-122.
[10] Korbecki J,Bajdak-Rusinek K.The effect of palmitic acid on inflammatory response in macrophages:An overview of molecular mechanisms[J].Inflamm Res,2019,68(11):915-932.
[11] 岳紫晨,音金萍,陈玲玲,等.健脾理气方通过下调NLRP3炎症小体的活化防治内毒素性急性肝损伤大鼠[J].中药药理与临床,2020,36(1):168-173.
[12] Mastrocola R,Aragno M,Alloatti G,et al.Metaflammation:Tissue-specific alterations of the NLRP3 inflammasome platform in metabolic syndrome[J].Curr Med Chem,2018,25(11):1294-1310.
[13] 卫 昊,张新玥.灵芝酸A对D-氨基半乳糖/脂多糖诱导小鼠肝损伤的保护作用[J].南京中医药大学学报,2019,35(4):432-435.
[14] 潮 蓉,武小娟,王羽辉,等.P2X7R/NLRP3信号通路在酒精性肝损伤中的作用[J].中国药理学通报,2018,34(4):491-495.
[15] Wang JF,Dong R,Zheng S.Roles of the inflammasome in the gut-liver axis[J].Mol Med Rep,2019,19(1):3-14.